ASI Announces Complete Topical Product Development Services
New partnership expands the capabilities of ASI to offer topical drug development services from concept to commercialization.
RESEARCH TRIANGLE PARK, N.C., Oct. 4, 2011 /PRNewswire-iReach/ -- Dr. Kailas Thakker and Dr. Vijendra NALAMOTHU today announced a new business partnership that will expand the capabilities of Analytical Solutions, Inc. (ASI) to include topical drug product development, from concept to commercialization. The new ASI provides all CMC related laboratory and consulting services for topicals, transdermals and specialty dosage forms to the pharmaceutical industry. Offerings include Topical Product Development, Complete Analytical Services, Drug Diffusion/Release Studies, CMC/Clinical/Regulatory Strategy Development, and Management of Client's Outsourced Projects to Contract Research Organizations and Contract Manufacturers. Clinical Manufacturing/Labeling and Skin Permeation Services will be available soon. Work is conducted in compliance with FDA GLP and cGMP regulations as required.
(Photo: http://photos.prnewswire.com/prnh/20111004/CG80852)
"We are very pleased to announce this new venture with Vijendra," said Dr. Thakker, President of ASI. "As our new Executive Vice President & COO, he brings a wealth of experience in topical product development, and has managed numerous projects from concept to commercialization."
Dr. NALAMOTHU joins ASI from Promius Pharma, a wholly owned subsidiary of Dr. Reddy's Labs, Inc., where he served as Head of R&D. In addition to heading Promius Pharma's R&D, he was also responsible for all of Dr. Reddy's global dermatological efforts. Dr. NALAMOTHU earned his doctoral degree in Pharmaceutics from University of the Sciences' Philadelphia College of Pharmacy. Prior to Dr. Reddy's, he was the Worldwide Head of the Preclinical and Early Formulation group at Sanofi-aventis Dermatology (Dermik Labs). His efforts over the last 16 years in various dermatological companies have led to many commercial products in the market today.
Dr. Thakker founded ASI 16 years ago in the Research Triangle Park area of North Carolina. Over the years, ASI has developed numerous in vitro release test methods to support both formulation development and post marketing changes in manufacturing processes, sites or product composition (per the FDA SUPAC-SS guidelines). After obtaining her doctoral degree in Pharmaceutical Chemistry from the University of Kansas, Dr. Thakker worked for the US Pharmacopeia where she worked in the Drug Research and Testing Laboratory, with an emphasis on dissolution methods.
Meet ASI at AAPS
ASI is exhibiting at the premier event of the AAPS Annual Meeting & Exposition in Washington, DC on October 24-26. Please visit Booth #1504 for more details about this new venture and a complete list of services.
About ASI
ASI is a Contract Research Organization serving the pharmaceutical and biotechnology industries. The company, founded by Dr. Kailas Thakker, a respected scientist and well known authority on in vitro release testing (IVRT), is now foraying into complete topical product development services.
Headquartered in Research Triangle Park, NC, ASI has a 4000+ sq. ft. research facility and soon will be adding a clinical manufacturing facility on its premises. For more information, please visit the ASI website at http://www.asi-rtp.com/ or contact Ms. Kathy Meserve at +1-919-549-9700 or [email protected]
Media Contact: Kathy Meserve of Sequoia Research, Inc., +1 (919) 549-9700, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Sequoia Research, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article